We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Anesthetic Approach Impedes Pain Without Affecting Motor Function

By HospiMedica International staff writers
Posted on 15 Feb 2010
Sensory-selective local anesthesia, a key goal in local anesthetic development, could soon be an attainable reality, according to a new study. More...


Researchers at Children's Hospital Boston (MA, USA) who wished to find an agent that would prolong anesthetics' effects, decided to test three different kinds of surfactant in conjunction with the anesthetics QX-314 and QX-222, both derivatives of lidocaine. But while the researchers found that this approach did prolong the sensory block in rats' sciatic nerves--for up to 7 hours or more depending on the surfactant--it surprisingly did prolong motor impairment, and in some cases the motor block was absent or of very short duration. In the rat models, this meant that the animals were able to tolerate having their paws on a hot plate for long periods, yet still were able to balance and bear weight on their legs.

The researchers suggested that the observed effect was due to a local interaction between the surfactant and the lidocaine derivative, not a systemic effect. They thus speculated that surfactant made the anesthetic better able to penetrate sensory nerves, which have little or none of the fatty coating known as myelin, whereas in motor neurons, which have abundant myelin, the active drug gets trapped in the myelin, never actually entering the nerve itself. The next step will be to explore the effects of different permeability enhancers and examine their safety, since at high doses the anesthetic and surfactant combination could potentially be toxic to the nerves. The eventual plan is to test the approach in larger animals. The study was published early online on February 1, 2010, in the Proceedings of the National Academy of Sciences (PNAS).

"This was a surprise finding,” said Daniel Kohane, M.D., Ph.D., of the division of critical care medicine. "What we've discovered really is a new approach; the question now is to figure out the mechanism by which it works and look at the effects of other chemical permeability enhancers.”

Myelin, an outgrowth of a glial cell, is a dielectric material that forms the myelin sheath, an insulating layer on the axon that is essential for the proper functioning of the nervous system. The main purpose of a myelin sheath is to increase the speed at which electrical impulses propagate; along unmyelinated fibers, impulses move continuously as waves, but in myelinated fibers, they hop or "propagate by saltation.” Myelin increases electrical resistance across the cell membrane by a factor of 5,000 and decreases capacitance by a factor of 50, thus preventing the electrical current from leaving the axon.

Related Links:
Children's Hospital Boston



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.